.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Indo Cannabis is stocked at 62 licensed dispensaries across Nevada, with the deepest coverage in Las Vegas, Henderson, Reno, North Las Vegas, and Carson City. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In July 2026, Indo Cannabis concentrated 53.96% of sales in Capsules with a month-over-month rise of 11.53% but a year-over-year decline of 47.22%, while Topical held 32.16% share with an 8.68% MoM drop and a 2.21% YoY decline. Vapor Pens expanded to 13.88% share on 778.80% YoY growth but contracted 15.47% MoM, and the brand’s average price fell 4.72% YoY as overall brand sales were down 26.85% YoY. With Capsules ranked number 1 in Nevada and anchoring more than half of mix, the pattern indicates reliance on a leading niche to stabilize volumes while price and category volatility reshape total sales trajectory.
The mix shift implies Indo Cannabis is trading depth for breadth: Capsules’ MoM rebound and top rank counterbalance Topical’s 8.68% MoM decline, while Vapor Pens’ triple-digit YoY surge adds reach despite a double-digit MoM pullback. The combination of a 4.72% YoY average price decrease and a 26.85% YoY sales contraction suggests the brand is leaning on price and a dominant Capsules position to defend share, while testing Vapor Pens as a secondary growth lane; the implication is that maintaining the number 1 Capsules rank in Nevada becomes the anchor strategy as Indo Cannabis prunes weaker Topical momentum and calibrates pen assortment for steadier month-over-month performance.
Competitive Landscape
Indo Cannabis ranks #1 in Nevada Capsules in July 2026, unchanged from #1 year over year, while improving from #2 three months ago to its peak at #1 in July 2026; by contrast, Level sits at #2 with a -42.8% year-over-year sales decline and Cannavative holds #3 after rising from #4 year over year despite an -82.5% drop in sales. With Indo Cannabis holding #1 both year over year and in July 2026, and competitors either slipping in sales or ceding rank momentum, the pattern implies Indo Cannabis has consolidated category leadership rather than merely cycling through temporary rank volatility.
Notable Products
Maxtabs - THC Capsules 10-Pack (100mg) posted the largest movement in July 2026 with a 51.99% month-over-month gain and climbed to rank 3, while CBD/CBN/THC 4:4:1 Jungle Stick IndoBalm (400mg CBD, 400mg CBN, 100mg THC) fell 12.40% and still held rank 1. Flow Bars Tablets 5-Pack (200mg) declined 12.56% at rank 6 and Raw Tablet 25-Pack (750mg) dropped 16.02% at rank 10, whereas CBD/THC/CBN 4:4:1 Jungle Stick Balm (400mg CBD, 400mg THC, 100mg CBN) rose 8.32% at rank 2. Six of the top ten are Capsules, concentrating share despite mixed performance, and this tilt implies Indo Cannabis is pivoting toward dose-controlled ingestibles even as Topicals remain the traffic anchor.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
